The FDA may not give credit for drugs that improve insulin sensitivity and glucose disposal if there are perceived easier ways to achieve these improvements.

“the FDA won't give them credit for that I don't think yeah but but I think that again it's harder to tease out because there's more moving pieces and they might argue there are easier ways to increase insulin sensitivity and glucose disposal”